Washington, D.C., April 18, 2018 – Clinical trial planning is underway at MedStar Heart & Vascular Institute to determine whether a novel stem cell therapy will improve heart function for patients with heart failure. MedStar Heart, in partnership with CardioCell, a subsidiary of Stemedica Cell Technologies, pioneered the use of stem cells in regenerative medicine. The trial will use CardioCell’s proprietary mesenchymal stem cells (MSCs), manufactured by Stemedica. The goal is to improve outcomes in patients with heart failure and left ventricular assist devices (LVAD). MedStar Heart & Vascular Institute has been studying the causes of the progressive deterioration of…

Read More

  Washington, D.C., February 12, 2018 – MedStar Heart & Vascular Institute’s cardiac surgery program has earned the highest quality rating of three stars from the prestigious Society of Thoracic Surgeons (STS), placing it once again among the top surgical heart programs in the nation. MedStar Heart & Vascular Institute, headquartered at MedStar Washington Hospital Center, received the highest, three-star rating in all three ranked categories: coronary artery bypass grafting (CABG), aortic valve replacement (AVR) and combined AVR + CABG. It’s an achievement shared by an elite group of less than five percent of cardiac surgery centers in the U.S.…

Read More

An important reminder during this flu season.  Washington, D.C., January 26, 2018 - To help protect our patients, visitors, and employees, we ask that visitors not bring children under the age of 14 to the hospital. This flu season is challenging, and our young visitors and patients are especially vulnerable. Thank you for your cooperation.   About MedStar Washington Hospital Center: MedStar Washington Hospital Center is a 912-bed, major teaching and research hospital. It is the largest private, not-for-profit hospital in the nation’s capital, among the 100 largest hospitals in the nation and a major referral center for treating the most…

Read More